Divence Tetra RSS Authorised This medicine is authorised for use in the European Union bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant) / bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccineMedicineVeterinaryAuthorised
Page contentsPage contents Overview Product details Authorisation details Assessment history News on Divence Tetra Application under evaluation CVMP opinion European Commission decision OverviewUp-to-date information on this veterinary medicinal product is available on the Veterinary Medicines Information website Product details Name of medicine Divence Tetra Active substance bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant)bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccine International non-proprietary name (INN) or common name bovine viral diarrhoea virus type 1 and type 2 (subunit recombinant)bovine parainfluenza 3 virus (inactivated) and bovine respiratory syncytial virus vaccine Pharmacotherapeutic groupImmunologicals for BovidaeLive and inactivated viral vaccines Authorisation details EMA product number EMEA/V/C/006222 Assessment history Initial marketing authorisation documents CVMP summary of positive opinion for Divence TetraAdopted Reference Number: EMA/CVMP/98737/2024 English (EN) (139.96 KB - PDF)First published: 18/03/2024 View News on Divence Tetra Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 9-10 September 202512/09/2025 Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 12-13 March 202418/03/2024 This page was last updated on 31/05/2024 Share this page